Project to focus on improving access to EstroGel.
LifeMD, Inc. revealed in a company press release that is has agreed to terms on a partnership with Ascend Therapeutics, a subsidiary of Besins Healthcare and a specialty pharmaceutical company concentrating on women's health. As per the deal, the collaboration aims to provide integrated telehealth services to improve access to EstroGel 0.06% (estradiol gel), with LifeMD’s telehealth services now available on Ascend’s website.
“This agreement with Ascend Therapeutics, a global market leader improving women’s lives with a focus on innovative hormone therapies, is an example of an increasing number of pharmaceutical partnerships applying LifeMD technology and aptitude in consumer healthcare engagement,” said Justin Schreiber, chairman, CEO, LifeMD. “By providing patient access to a high-quality physician at the moment they are searching for treatment, we are removing barriers to care – like lengthy appointment wait times and risk of inconsistent care by less experienced practitioners – while also improving health outcomes by providing on-demand and ongoing access to primary care providers.”
Reference: LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy. LifeMD. September 21, 2023. Accessed September 22, 2023. https://ir.lifemd.com/press-release-details.php#/?newsId=2747072
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.